Reprogrammed Cell‐based Therapy for Liver Disease: From Lab to Clinic
A large number of patients are affected by liver dysfunction worldwide. Liver transplantation is the only efficient treatment in a variety of enduring liver disorders including inherent and end-stage liver diseases. The generation of human functional hepatocytes in high quantities for liver cell the...
Saved in:
| Main Authors: | Amir Mehdizadeh, Masoud Darabi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Troika Publisher
2017-02-01
|
| Series: | Journal of Renal and Hepatic Disorders |
| Online Access: | https://jrenhep.com/index.php/jrenhep/article/view/6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Stearoyl-coenzyme A Desaturase 1 in Liver Development, Function, and Pathogenesis
by: Fatemeh Mohammadzadeh, et al.
Published: (2019-02-01) -
From lab to lifesaver: the rise of CAR T-cell therapy in oncology
by: Shriyash S. Jangavali, et al.
Published: (2025-05-01) -
Metabolic reprogramming induced by fructose promotes therapy´s failure in liver cancer cells in vitro and in vivo.
by: Lisette Chávez-Rodríguez, et al.
Published: (2025-04-01) -
The performance of the alarmin HMGB1 in pediatric diseases: From lab to clinic
by: Bo Li, et al.
Published: (2021-03-01) -
Somatic cell reprogramming for Parkinson's disease treatment
by: Xiaozhuo Li, et al.
Published: (2025-03-01)